10-28-2021, 11:24 AM
I totally agree on "marketing" playing a big role in the 1 versus 2 dose approach that the various companies pursued, and also in the lack of emergence of a 4th vaccine. I hypothesize J&J may have been trying to differentiate themselves as more convenient.  And in fairness, for some regions of the world that may be a great approach.